Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
450.00    -3.60 (-0.79%)
Bid:
451.30
Ask:
451.60
Spread: 0.30 (0.066%)
Market Cap: £11.32b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

?50m Floating Rate Notes due 2013

14 Oct 2008 12:52

RNS Number : 8049F
Rentokil Initial PLC
14 October 2008
Β 

ο»Ώ

Rentokil Initial plc

Β£50m Floating Rate Notes due 2013

Rentokil Initial plcΒ (theΒ "Company")Β announces that it has entered into a commitment with an investorΒ who will purchase Β£50m Floating Rate Notes due 2013Β (the "FRNs"). TheΒ FRNsΒ are expected to beΒ issuedΒ at parΒ underΒ the Company'sΒ existingΒ Euro Medium Term Note ProgrammeΒ and carry a coupon of LIBOR +Β 3.25%.Β Β The FRNs are expected to be issued before the end ofΒ October 2008Β and to beΒ guaranteed by Rentokil Initial 1927 plc, a wholly owned subsidiary of the Company.

Rentokil Initial 1927 plcΒ currently guarantees the obligations ofΒ the CompanyΒ to its bondholders, banks and certain other financial counterparties. These guaranteesΒ wereΒ due to expire on 19Β November 2008Β but will nowΒ be extendedΒ toΒ match the maturity of the Company's Β£300Β millionΒ 5.75 per cent.Β NotesΒ dueΒ 2016,Β issued by the Company inΒ March 2006, and the FRNs, whicheverΒ maturityΒ is the later.

During the last two months, Rentokil Initial has announced the issue of Β£125m of newΒ debt securities (beingΒ the FRNs and theΒ Β£75 million Floating Rate Reset Notes due 2033 (the "PCRs")). TheΒ Company's Β£250m 6.125 per cent. notes due 2008 (the "Notes")Β will mature on 19Β November 2008 and will be repaid from the Company's bank facilities. The Company estimates that it will have at least Β£350m ofΒ headroomΒ in its committed facilities after repaying theΒ Notes.Β Β At least Β£100m ofΒ thatΒ headroomΒ isΒ provided by a facility whichΒ is due toΒ expireΒ in 2012. The balance is provided by a second facility which is extendable at the Company's option toΒ JanuaryΒ 2010.Β 

After November 2008, the next maturityΒ of the Company's bond indebtedness will be in 2013 if the holders of the PCRs exercise their right toΒ require repayment.

For further information

Shareholder/analyst enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 020 7592 2700

Media enquiries:

Malcolm Padley, Head of Corporate Communications Rentokil Initial plc 020 7592 2700

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFFUFFLSASELS
Date   Source Headline
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company
14th Oct 20229:30 amRNSAdditional Listing
13th Oct 20225:42 pmRNSHolding(s) in Company
13th Oct 20223:05 pmRNSHolding(s) in Company
12th Oct 20221:53 pmRNSAcquisition of Terminix Completion
10th Oct 20221:57 pmRNSHolding(s) in Company
10th Oct 20221:52 pmRNSHolding(s) in Company
10th Oct 20221:38 pmRNSHolding(s) in Company
7th Oct 20226:10 pmRNSRentokil Initial
6th Oct 20222:23 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.